Home » Topics » Regulatory » EMA

EMA
RSS

CHMP recommends conditional marketing approval for Votrient

April 27, 2010

CHMP recommends Seroquel XR as add-on treatment for major depressive disorder

April 27, 2010

EMA's CHMP recommends extending indication of tocilizumab

April 27, 2010

EMA's COMP notifies CytRX of positive opinion on bafetinib in CML

April 22, 2010

EMA recommends Cell Therapeutics submit revised PIP for pixantrone

April 22, 2010

European Joulferon MAA for chronic hepatitis C withdrawn

April 21, 2010

Aeterna Zentaris receives advice from the EMA for phase III perifosine program

April 16, 2010

Raloxifene decreases epistaxis in hereditary hemorrhagic telangiectasia / News in Context

April 13, 2010

EMA grants orphan drug designation to Protalix's taliglucerase alfa for Gaucher's disease

March 30, 2010

Bioalliance Pharma's antiemetic Setofilm approved in Europe

March 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 2, 2025.
CMS vows to put more emphasis on MA plans’ prior authorization
BioWorld MedTech
Physicians aren’t the only ones who see prior authorization (PA) practices as a significant problem, but John Brooks, deputy administrator at CMS, told a med tech...
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
Filling the NIH funding gap to protect biopharma research
BioWorld
The Trump administration’s broad slash to university research budgets raises pertinent questions over impacts to the biopharma ecosystem, specifically how a...